… to rank immunomodulators in the treatment of COVID-19 according to their efficacy and …
rank immunomodulators in the treatment of COVID-19 according to their efficacy and safety. …

… role and safety of these agents in the management of severe COVID-… safety of anakinra in
treating COVID-19. In a small case-series of nine patients with moderate to severe COVID-19 …

… potential benefits from other immunomodulators that could, … , hospitalised patients with
COVID-19 can develop a syndrome of … safety profile with risk for infection and demonstrated safety …

… the oxidative stress produced by COVID-19, as well as prophylaxis … use of immunomodulators
for the management of COVID-19. … Moreover, a RCT supported the safety and tolerability of …

… on the safety and immunogenicity of COVID … safety and immunogenicity of the mRNA
COVID-19 vaccine among adolescents with juvenile-onset AIIRDs treated with immunomodulatory …

… Thus, considering the antiviral and immunomodulatory properties of the anti-malarials
and the pre-clinical evidence of effectiveness and safety from long-time clinical use for other …

… immunomodulatory agents with good safety profiles may be considered for use in combination
with antiviral drugs for the treatment of severe or critical cases of COVID-19 (Table 1 ). …

… was an RCT that was stopped early) assessing the safety and efficacy of HIG and CP use.
In these … The review found low-certainty evidence for safety of CP for COVID-19. However, a …

… The main objective of these included publications and clinical trials was determining the
safety and efficacy of the various immunomodulatory medicines in patients with mild/moderate-to…

… be relevant to the alleviation of COVID-19 symptoms. While the use … needs of COVID-19
patients, plus a favorable safety profile at … of respiratory symptoms in COVID-19 patients could be …